Sofosbuvir + Velpatasvir + Voxilaprevir

Category: Hepatitis

Sofosbuvir + Velpatasvir + Voxilaprevir Overview

Voxilaprevir is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor (by Gilead) that is used in combination with sofosbuvir and velpatasvir.[2] The combination has the trade name Vosevi and received a positive opinion from the European Committee for Medicinal Products for Human Use in June 2017.[3] On 18 July 2017, Vosevi was approved by the US Food and Drug Administration.[4] References .mw-parser-output .reflist{fon...

Read more Sofosbuvir + Velpatasvir + Voxilaprevir Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Sofosbuvir + Velpatasvir + Voxilaprevir Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sofosbuvir + Velpatasvir + Voxilaprevir
  • Tablet: 400mg + 100mg + 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (7 results)

Related Sofosbuvir + Velpatasvir + Voxilaprevir Topics:

Which is the efficiency of the Ledipasvir + Sofosbuvir?
Please, be so kind and tell me if you have some reference about "LEDVIR", do you think that this medicine could ...